HES3
gene geneOn this page
Also known as bHLHb43
Summary
HES3 (hes family bHLH transcription factor 3, HGNC:26226) is a protein-coding gene on chromosome 1p36.31, encoding Transcription factor HES-3 (Q5TGS1). Transcriptional repressor of genes that require a bHLH protein for their transcription.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of neurogenesis. Predicted to act upstream of or within several processes, including nervous system development; regulation of timing of neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 390992 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_001024598
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26226 |
| Approved symbol | HES3 |
| Name | hes family bHLH transcription factor 3 |
| Location | 1p36.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bHLHb43 |
| Ensembl gene | ENSG00000173673 |
| Ensembl biotype | protein_coding |
| OMIM | 609971 |
| Entrez | 390992 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000377898, ENST00000706530
RefSeq mRNA: 1 — MANE Select: NM_001024598
NM_001024598
CCDS: CCDS41238
Canonical transcript exons
ENST00000377898 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001182530 | 6244548 | 6244629 |
| ENSE00001475445 | 6245110 | 6245578 |
| ENSE00003996079 | 6244351 | 6244446 |
| ENSE00003996080 | 6244179 | 6244241 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 37.20.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 3.2279 / max 429.4280, expressed in 142 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 367 | 3.2279 | 142 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.22 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.79 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.06 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| monocyte | CL:0000576 | 27.01 | gold quality |
| urinary bladder | UBERON:0001255 | 26.89 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.14 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| frontal cortex | UBERON:0001870 | 25.21 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 25.01 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 24.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 23.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.33 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| HES1 | Repression |
Upstream regulators (CollecTRI, top): HEY1, NANOG, POU5F1, RBPJ, SOX2
Literature-anchored findings (GeneRIF, showing 7)
- CXorf6 transactivates the Hes3 promoter, augments testosterone production (PMID:18162467)
- Hes3 is expressed in cultures from glioblastoma multiforme which express neural stem cell markers (PMID:23393614)
- expression of the transcription factor Hes3 in the mouse and human ocular surface, and in pterygium (PMID:24512568)
- Data show that transcription factor Hes3 is expressed in adult pancreatic islets and dissociated cultures of pancreatic islet cells. (PMID:25371201)
- The STAT3-Ser/Hes3 Signaling Axis was first identified as a major regulator of neural stem cells and, subsequently, cancer stem cells (PMID:26783739)
- HES3 overexpression is associated with impaired myogenic differentiation and rhabdomyosarcoma tumorigenesis. (PMID:29869612)
- Hes3 regulated cell proliferation and lung cancer invasion.Hes3 regulated Cyclin D1, Cyclin D3 and MMP7 expression in lung cancer cells. (PMID:30911281)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | her3 | ENSDARG00000076857 |
| mus_musculus | Hes3 | ENSMUSG00000028946 |
| rattus_norvegicus | Hes3 | ENSRNOG00000010893 |
| drosophila_melanogaster | E(spl)m8-HLH | FBGN0000591 |
| drosophila_melanogaster | E(spl)m3-HLH | FBGN0002609 |
| drosophila_melanogaster | E(spl)m5-HLH | FBGN0002631 |
| drosophila_melanogaster | E(spl)m7-HLH | FBGN0002633 |
| drosophila_melanogaster | E(spl)mbeta-HLH | FBGN0002733 |
| drosophila_melanogaster | E(spl)mdelta-HLH | FBGN0002734 |
| drosophila_melanogaster | E(spl)mgamma-HLH | FBGN0002735 |
| drosophila_melanogaster | Hesr | FBGN0030899 |
| drosophila_melanogaster | cwo | FBGN0259938 |
Paralogs (12): HES2 (ENSG00000069812), HES1 (ENSG00000114315), BHLHE41 (ENSG00000123095), BHLHE40 (ENSG00000134107), HEY2 (ENSG00000135547), HES6 (ENSG00000144485), HEYL (ENSG00000163909), HEY1 (ENSG00000164683), HES7 (ENSG00000179111), HELT (ENSG00000187821), HES4 (ENSG00000188290), HES5 (ENSG00000197921)
Protein
Protein identifiers
Transcription factor HES-3 — Q5TGS1 (reviewed: Q5TGS1)
Alternative names: Class B basic helix-loop-helix protein 43, Hairy and enhancer of split 3
All UniProt accessions (2): Q5TGS1, A0A9L9PX90
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor of genes that require a bHLH protein for their transcription.
Subunit / interactions. Transcription repression requires formation of a complex with a corepressor protein of the Groucho/TLE family.
Subcellular location. Nucleus.
Domain organisation. Has a particular type of basic domain (presence of a helix-interrupting proline) that binds to the N-box (CACNAG), rather than the canonical E-box (CANNTG). The C-terminal WRPW motif is a transcriptional repression domain necessary for the interaction with Groucho/TLE family members, transcriptional corepressors recruited to specific target DNA by Hairy-related proteins.
RefSeq proteins (1): NP_001019769* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011598 | bHLH_dom | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050370 | HES_HEY | Family |
Pfam: PF00010
UniProt features (6 total): domain 2, chain 1, region of interest 1, short sequence motif 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TGS1-F1 | 64.65 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 53 (showing top):
BENPORATH_ES_WITH_H3K27ME3, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, SHIN_B_CELL_LYMPHOMA_CLUSTER_2, LEE_AGING_NEOCORTEX_DN, GOBP_REGULATION_OF_CELL_DEVELOPMENT, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr1p36, MEISSNER_BRAIN_HCP_WITH_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, SHEPARD_CRASH_AND_BURN_MUTANT_DN
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), anterior/posterior pattern specification (GO:0009952), regulation of neurogenesis (GO:0050767)
GO Molecular Function (4): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), protein dimerization activity (GO:0046983), DNA binding (GO:0003677)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| regionalization | 1 |
| neurogenesis | 1 |
| regulation of nervous system development | 1 |
| regulation of cell development | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
602 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HES3 | HEYL | Q9NQ87 | 600 |
| HES3 | HES6 | Q96HZ4 | 569 |
| HES3 | HEY1 | Q9Y5J3 | 557 |
| HES3 | MIXL1 | Q9H2W2 | 516 |
| HES3 | MAMLD1 | Q13495 | 504 |
| HES3 | RBPJ | Q06330 | 469 |
| HES3 | NHLH1 | Q02575 | 462 |
| HES3 | NKX2-5 | P52952 | 451 |
| HES3 | FGF2 | P09038 | 431 |
| HES3 | TLE4 | Q04727 | 429 |
| HES3 | POU5F1 | P31359 | 425 |
| HES3 | ASCL1 | P50553 | 417 |
| HES3 | JAG1 | P78504 | 411 |
| HES3 | PAX6 | P26367 | 409 |
| HES3 | LHX9 | Q9NQ69 | 406 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HES3 | SRC | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): SRC (Affinity Capture-MS), HCCS (Affinity Capture-MS), NRN1 (Affinity Capture-MS), HES3 (Affinity Capture-MS)
ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4
Diamond homologs: G5EF76, O54792, O57337, P13097, P14003, P29303, P35428, P35429, P70120, Q00P32, Q01068, Q01069, Q01070, Q01071, Q03062, Q04666, Q04667, Q07291, Q14469, Q26263, Q28HA8, Q3ZBG4, Q5PPM5, Q5TA89, Q5TGS1, Q61657, Q6IRB2, Q6PBD4, Q8AVU4, Q8BKT2, Q8UW72, Q8UW74, Q90VV1, Q90Z12, Q9BYE0, Q9HCC6, Q9Y543, A6NFD8, P13096, P13098
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
363 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:6244443:CCAGG:C | donor_loss | 1.0000 |
| 1:6244444:CAGG:C | donor_loss | 1.0000 |
| 1:6244445:AGGT:A | donor_loss | 1.0000 |
| 1:6244446:GGTGA:G | donor_loss | 1.0000 |
| 1:6244447:G:GA | donor_loss | 1.0000 |
| 1:6244546:A:AG | acceptor_gain | 1.0000 |
| 1:6244547:G:GG | acceptor_gain | 1.0000 |
| 1:6244257:GGAC:G | donor_gain | 0.9900 |
| 1:6244447:G:GG | donor_gain | 0.9900 |
| 1:6244448:T:A | donor_loss | 0.9900 |
| 1:6244537:T:TA | acceptor_gain | 0.9900 |
| 1:6244541:C:A | acceptor_gain | 0.9900 |
| 1:6244542:G:A | acceptor_gain | 0.9900 |
| 1:6244543:GGTA:G | acceptor_loss | 0.9900 |
| 1:6244544:GTAGA:G | acceptor_loss | 0.9900 |
| 1:6244627:AAG:A | donor_loss | 0.9900 |
| 1:6244630:G:A | donor_loss | 0.9900 |
| 1:6244594:TG:T | donor_gain | 0.9800 |
| 1:6244595:G:GT | donor_gain | 0.9800 |
| 1:6245106:ACAG:A | acceptor_gain | 0.9800 |
| 1:6245106:ACAGG:A | acceptor_gain | 0.9800 |
| 1:6245108:A:AG | acceptor_gain | 0.9800 |
| 1:6245108:AG:A | acceptor_gain | 0.9800 |
| 1:6245108:AGG:A | acceptor_gain | 0.9800 |
| 1:6245109:G:GG | acceptor_gain | 0.9800 |
| 1:6245109:GG:G | acceptor_gain | 0.9800 |
| 1:6245109:GGG:G | acceptor_gain | 0.9800 |
| 1:6245109:GGGC:G | acceptor_gain | 0.9800 |
| 1:6245109:GGGCT:G | acceptor_gain | 0.9800 |
| 1:6244258:G:T | donor_gain | 0.9700 |
AlphaMissense
1178 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:6244590:A:C | S42R | 0.997 |
| 1:6244592:C:A | S42R | 0.997 |
| 1:6244592:C:G | S42R | 0.997 |
| 1:6244391:T:C | I9T | 0.996 |
| 1:6244571:G:C | K35N | 0.995 |
| 1:6244571:G:T | K35N | 0.995 |
| 1:6244567:A:T | E34V | 0.993 |
| 1:6244378:C:A | R5S | 0.992 |
| 1:6244569:A:C | K35Q | 0.992 |
| 1:6244582:T:A | L39Q | 0.990 |
| 1:6244370:A:T | E2V | 0.989 |
| 1:6244371:G:C | E2D | 0.989 |
| 1:6244371:G:T | E2D | 0.989 |
| 1:6244412:T:C | L16P | 0.989 |
| 1:6244416:G:C | K17N | 0.989 |
| 1:6244416:G:T | K17N | 0.989 |
| 1:6244369:G:A | E2K | 0.985 |
| 1:6244568:G:C | E34D | 0.985 |
| 1:6244568:G:T | E34D | 0.985 |
| 1:6244569:A:G | K35E | 0.985 |
| 1:6244388:G:C | R8P | 0.984 |
| 1:6244579:T:C | I38T | 0.984 |
| 1:6244582:T:C | L39P | 0.984 |
| 1:6244395:T:A | N10K | 0.983 |
| 1:6244395:T:G | N10K | 0.983 |
| 1:6244374:A:C | K3N | 0.982 |
| 1:6244374:A:T | K3N | 0.982 |
| 1:6244391:T:G | I9S | 0.982 |
| 1:6244412:T:A | L16H | 0.982 |
| 1:6244566:G:A | E34K | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000041902 (1:6244851 G>C), RS1001336111 (1:6242577 C>T), RS1001826607 (1:6245892 C>A,T), RS1002664761 (1:6243055 T>G), RS1002686824 (1:6242861 A>G), RS1003020465 (1:6242768 C>A), RS1003357342 (1:6245566 T>A), RS1003868552 (1:6243834 G>C,T), RS1004516957 (1:6242715 G>A), RS1004630083 (1:6242429 C>T), RS1006189645 (1:6243956 G>A), RS1006241969 (1:6244871 G>A), RS1006474065 (1:6244929 C>G,T), RS1007510131 (1:6242198 G>C), RS1008743937 (1:6242322 G>A)
Disease associations
OMIM: gene MIM:609971 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| decabromobiphenyl ether | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| tetrachlorodian | decreases expression | 1 |
| Cyclic AMP | affects cotreatment, decreases expression | 1 |
| Ascorbic Acid | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cadmium | increases expression | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.